Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Half-dose Prasugrel and Ticagrelor in Korean ACS Patients (HOPE-TAILOR)
NCT02944123Phase 3Completed
- Sponsor
- Dong-A University
- Start
- Sep 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prasugrel and ticagrelor in acute coronary syndrome (ACS), sponsored by Dong-A University. Started Sep 2016; status: completed.
02
Drugs
prasugrelticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02944123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02944123.